Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

U.S. Risers/Fallers: Valeant, Piedmont, Roper, Xerox, GM, Concordia, FedEx

Below are the main news driven share price changes at 11:33 a.m. in New York on Monday:

RISERS

Piedmont Natural Gas (NYSE:PNY) surged 39.6% to $58.92. Duke Energy is buying the energy services company for $4.9bn in cash, or $60 per share. That represents a 42% premium for Piedmont shareholders over Friday's closing price.

Roper Technologies (NYSE:ROP) advanced 2.7% to $182.10 after the maker of software and engineered products reported adjusted quarterly profit above estimates.

FALLERS

Valeant Pharmaceuticals (NYSE:VRX) fluctuated and was last down 0.1% at $116.87. Canada’s largest pharmaceutical company said it has formed a committee to review allegations against it.

General Motors (NYSE:GM) skidded 1.5% to $35.41 after the largest U.S. automaker reached a tentative agreement with the United Auto Workers union on a new four-year contract, avoiding a strike for now.

Xerox (NYSE:XRX) slipped 1.9% to $10.15, reversing an earlier gain. The company synonymous with paper copiers and printers said it would undertake a “comprehensive review of structural options,” while it posted its first quarterly loss since 2010 on a hefty charge. Shares gained in premarket trades.

FedEx (NYSE:FDX) inched down 0.4% to $158.88, erasing an earlier increase. The package delivery company said it expects to see a record number of shipments during this year's busy holiday season, buoyed by rising retail sales and a jump in ecommerce.

Concordia Healthcare (NASDAQ:CXRX) fell 1.5% to $32.71. The Canada-based healthcasre company said it expects to more than double the size of its business following the close of its acquisition of Amdipharm Merc. on Oct. 21, forecasting revenue of $1.02bn to $1.06bn for fiscal 2016.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK